Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
批准号:
10298668
负责人:
KIRSTEN Jeanne LAMPI
金额:
$39.85万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-30 至 2025-06-30
关键词:
AddressAgeAge of OnsetAgingAntioxidantsCataractCell NucleusChemicalsCrystalline LensCrystallinsDataDeuteriumDevelopmentDiseaseDistantDisulfidesEnvironmentEtiologyGlutamineGlutathioneGoalsGrantHumanHydrogenIn VitroLaboratoriesLeadLinkMass Spectrum AnalysisMediatingMethodsModificationNuclearOxidesPathway interactionsPharmaceutical PreparationsPost-Translational Protein ProcessingPredispositionProcessProtein DynamicsProteinsReportingResolutionStructureTestingWorkage relatedagedamyloid fibril formationbiophysical propertiescrosslinkdeamidationdimerdisulfide bondexperimental studygamma-Crystallinsin vivoinsightion mobilitylenslight scatteringmodel developmentmolecular modelingnon-Nativeoxidationpeptide Aprotein aggregationresponsetherapeutic development
中文摘要
项目总结:
我们的实验室专注于我们已确定的最普遍的化学修饰
与存在于晶状体细胞核中的不溶蛋白质有关--脱酰胺和氧化。这些
修饰与年龄相关的核性白内障最相关,这是迄今为止最常见的白内障类型。在……里面
在这项拟议的工作中,我们将研究脱酰胺和氧化之间的相互作用,以模拟
晶状体中与年龄有关的过程。尽管晶状体环境通常处于还原状态,但晶状体的氧化
晶体蛋白中的巯基长期以来被认为与老年性白内障有关,因为晶状体中含有谷胱甘肽。
随着晶状体中心年龄的增长而减少。非天然二硫化物交联结晶的形成
因此,通过氧化半胱氨酸残基的亚基预计是导致
晶状体蛋白的聚集和不溶解。在目标1中,我们将确定具体的、与年龄相关的
γ中的脱氨基S通过鉴定反应形成的非天然二硫键促进其聚集
联合脱酰亚胺和氧化。在目标2中,我们将检验非天然二硫键的假设
形成较高有序的γS齐聚物,而AIMS 1和2的焦点是氧化
疯狂的γS,Aim 3探索了γS中的这些与年龄相关的修改是否会导致非本地交叉链接
γ-和β-晶体蛋白亚基之间的相互作用,从而打乱晶体蛋白的天然四元排列。
总体而言,这些发现将阐明脱酰胺,一种自发的修饰,如何有助于
氧化驱动的聚集级联反应是老年性核性白内障的基础。确立这一点
脱酰亚胺主要通过加强晶体蛋白的氧化来调节其作用,从而提供
旨在延缓年龄相关核发病的治疗策略发展的稳健模型
通过恢复晶状体的抗氧化剂水平来防治白内障。这项工作也将对
长寿命蛋白的脱酰胺和氧化与淀粉样原纤维相关的其他几种疾病
队形。
英文摘要
Project Summary:
Our laboratories have focused on the most prevalent chemical modifications that we have identified to be
associated with the insoluble proteins present in the nucleus of the lens- deamidation and oxidation. These
modifications are most relevant to age-related nuclear cataract, by far the most common type of cataract. In
this proposed work, we will examine the interplay between deamidation and oxidation in order to mimic the
age-related processes in the lens. Although the lens environment is normally in a reduced state, oxidation of
sulfhydryls in crystallins has long been associated with age-related cataract as the pool of lens glutathione
diminishes with aging in the center of the lens. The formation of non-native, disulfide crosslinked crystallin
subunits via the oxidation of Cys residues is therefore anticipated to be a key process leading to the
aggregation and insolubilization of lens proteins. In Aim 1, we will determine how specific, age-related
deamidations in γS promote its aggregation by identifying non-native disulfide bond formed in response to
combined deamidation and oxidation. In Aim 2, we will test the hypothesis that non-native disulfide bond
formation leads to higher ordered oligomers of γS. While the focus of Aims 1 and 2 is the oxidation of
deamidated γS, Aim 3 explores whether these age-related modifications in γS lead to non-native crosslinks
between γ- and β-crystallin subunits and thereby disrupt the native quaternary arrangement of the crystallins.
Overall, these findings will elucidate how deamidation, a spontaneous modification, contributes to the
oxidation-driven aggregation cascade that underlies age-related nuclear cataract. Establishing that
deamidation mediates its effects predominantly via augmenting the oxidation of crystallin proteins will provide a
robust model for the development of therapeutic strategies aiming to delay the onset of age-related nuclear
cataract by restoring the antioxidant levels of the lens. The work will also have significant implications for
several other diseases where deamidation and oxidation of long-lived proteins is associated with amyloid fibril
formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Opening Dental and Oral Research Summers (DORS) to Scientific Careers throughout Oregon
-
批准号:10598424
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2023
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
-
批准号:10655486
-
项目类别:
-
资助金额:$37.15万
-
财政年份:2016
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
-
批准号:10468857
-
项目类别:
-
资助金额:$36.04万
-
财政年份:2016
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
FLUORIDE BIOMARKERS
-
批准号:7206634
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2005
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
BIOMARKERS FOR TOTAL BODY BURDEN OF FLUORIDE
-
批准号:6775616
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
DEAMIDATION AND HUMAN BETA CRYSTALLIN STRUCTURE
-
批准号:6524951
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
DEAMIDATION AND HUMAN BETA CRYSTALLIN STRUCTURE
-
批准号:2888624
-
项目类别:
-
资助金额:$10.01万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of deamidation in human beta-crystallin structure
-
批准号:8288836
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of Deamidation in Human Beta-Crystallin Structure
-
批准号:6874875
-
项目类别:
-
资助金额:$25.41万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of deamidation in human beta-crystallin structure
-
批准号:7737509
-
项目类别:
-
资助金额:$33.03万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
DEAMIDATION AND HUMAN BETA CRYSTALLIN STRUCTURE
-
批准号:6384753
-
项目类别:
-
资助金额:$19.4万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of Deamidation in Human Beta-Crystallin Structure
-
批准号:7213283
-
项目类别:
-
资助金额:$25.26万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
DEAMIDATION AND HUMAN BETA CRYSTALLIN STRUCTURE
-
批准号:2676482
-
项目类别:
-
资助金额:$9.6万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
DEAMIDATION AND HUMAN BETA CRYSTALLIN STRUCTURE
-
批准号:6179034
-
项目类别:
-
资助金额:$10.41万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of deamidation in human beta-crystallin structure
-
批准号:8103927
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Deamidation in Human Beta-Crystallin Structure
-
批准号:6776054
-
项目类别:
-
资助金额:$26.27万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
Role of Deamidation in Human Beta-Crystallin Structure
-
批准号:7034521
-
项目类别:
-
资助金额:$25.65万
-
财政年份:1998
-
负责人:KIRSTEN Jeanne LAMPI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: